ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in New York, NY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Brain Cancer
Glioma
Astrocytoma
Cancer
Recurrence
Gliosarcoma

Glioblastoma (GBM) trials near New York, NY, USA:

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER)

FRONTIER Study is a prospective, interventional, single-arm, multi-center, study to assess the safety and technical feasibility of TheraSphere GBM...

Enrolling
Recurrent Glioblastoma
Glioblastoma Multiforme
Device: TheraSphere GBM

Phase 1

Boston Scientific
Boston Scientific

New York, New York, United States and 8 other locations

efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...

Active, not recruiting
Glioblastoma
Drug: Temozolomide
Biological: INO-9012

Phase 1, Phase 2

Inovio Pharmaceuticals
Inovio Pharmaceuticals

New York, New York, United States and 20 other locations

(SOC) will improve survival in adult patients newly diagnosed with glioblastoma (IDH-wt). It will also evaluate the safety of DOC1021 + pIFN...

Enrolling
Glioblastoma (GBM)
Drug: Temodar (Temozolomide)
Biological: DOC1021

Phase 2

Diakonos Oncology Corporation

Summit, New Jersey, United States and 10 other locations

A Phase 1b/2, Multicenter, Open-Label Study of ACP-196 in Subjects with Recurrent Glioblastoma Multiforme (GBM)...

Active, not recruiting
Glioblastoma Multiforme
Drug: ACP-196

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

New York, New York, United States and 6 other locations

This is a Phase 3 prospective, randomized, superiority, open-label, multi-site study. The overview of this study is as follows:* A Screening/Baseline...

Enrolling
Glioblastoma
Radiation: External Beam Radiation Therapy
Drug: Temozolomide

Phase 3

GT Medical Technologies

Valhalla, New York, United States and 1 other location

(MTA-based vaccine) in combination with standard care treatment of glioblastoma (GBM) and Tumor Treating Fields (TTFields).The stud...

Active, not recruiting
Glioblastoma
Biological: Peptides
Drug: Poly-ICLC

Phase 1

Adilia Hormigo

The Bronx, New York, United States and 1 other location

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling
Glioblastoma
Drug: Temozolomide
Radiation: Radiation

Phase 2, Phase 3

Global Coalition for Adaptive Research

New York, New York, United States and 61 other locations

therapy alone as a treatment for newly diagnosed MGMT unmethylated glioblastoma patients. The patients' own cancer cells collected after sur...

Active, not recruiting
Glioblastoma Multiforme of Brain
Radiation: Radiotherapy
Procedure: Standard of Care

Phase 2, Phase 3

TVAX Biomedical

Pennington, New Jersey, United States and 7 other locations

with ipilimumab and surgery when used in the treatment of recurrent glioblastoma.The names of the study drugs involved in this study are:* N...

Active, not recruiting
Glioblastoma
Glioblastoma Multiforme
Drug: Ipilimumab-Placebo
Drug: Nivolumab-Placebo

Phase 1

Patrick Wen, MD

New York, New York, United States and 3 other locations

Optune® together with maintenance TMZ and placebo in newly diagnosed Glioblastoma (GBM) patients. The primary objective of the stud...

Enrolling
Glioblastoma
Drug: Temozolomide
Drug: Placebo

Phase 3

NovoCure
NovoCure

New York, New York, United States and 71 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems